Description

The Missionad Study program is a clinical research program testing an investigational drug for the early stages of Alzheimer’s disease. (“Investigational” means the drug isn’t yet approved for use by the public.) Doctors are studying this investigational drug to make sure it is safe and to see if it may help people with Alzheimer’s disease in the future.

The post The MissionAD study for early stages of Alzheimer’s disease…Currently Enrolling appeared first on Palm Beach Neurological Center.